Now seven pharmaceutical companies are reporting shortages of a common treatment for ADHD and narcolepsy. The shortage affects roughly 2.5 million Americans with ADHD.
Europe s drugmakers have
warned they may stop making some cheap generic medicines because
of surging electricity costs and are calling for an overhaul of
the way they are priced, the latest industry. | September 28, 2022